BPM PE HC Interactions
There are 771 drugs known to interact with BPM PE HC (brompheniramine / hydrocodone / phenylephrine), along with 24 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 235 are major, 532 are moderate, and 4 are minor.
- View all 771 medications that may interact with BPM PE HC
- View BPM PE HC alcohol/food interactions (2)
- View BPM PE HC disease interactions (24)
Most frequently checked interactions
View interaction reports for BPM PE HC (brompheniramine / hydrocodone / phenylephrine) and the medicines listed below.
- Benicar (olmesartan)
- Benicar (olmesartan)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- Bupap (acetaminophen / butalbital)
- Bupap (acetaminophen / butalbital)
- cephalexin
- cephalexin
- codeine / promethazine
- codeine / promethazine
- cyclobenzaprine
- cyclobenzaprine
- Depakote ER (divalproex sodium)
- Depakote ER (divalproex sodium)
- nystatin
- nystatin
- Pepcid AC (famotidine)
- Pepcid AC (famotidine)
- Topamax (topiramate)
- Topamax (topiramate)
- Zantac (ranitidine)
- Zantac (ranitidine)
BPM PE HC alcohol/food interactions
There are 2 alcohol/food interactions with BPM PE HC (brompheniramine / hydrocodone / phenylephrine).
BPM PE HC disease interactions
There are 24 disease interactions with BPM PE HC (brompheniramine / hydrocodone / phenylephrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- BPH
- diabetes
- glaucoma
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Promethazine VC with Codeine
Promethazine VC with Codeine is used for cough and nasal congestion
Mucinex D
Mucinex D (guaifenesin and pseudoephedrine) is used to treat nasal and sinus congestion, and to ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Robitussin Nighttime Cough DM
Robitussin Nighttime Cough DM is used for cough, cough and nasal congestion
Dextromethorphan/guaifenesin/phenylephrine
Dextromethorphan/guaifenesin/phenylephrine is used for cough and nasal congestion
Brompheniramine/dextromethorphan/pseudoephedrine
Brompheniramine/dextromethorphan/pseudoephedrine is used for cough and nasal congestion
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.